With more than 20 years of experience in neurology, Fabio Danisi, M.D., joined MidHudson Regional Hospital, in Poughkeepsie, NY, in 2015 as associate director of neurology. He also serves as section chief of movement disorders at Westchester Medical Center.
Dr. Danisi is active in the field of movement disorders and is skilled in the diagnosis and treatment of disorders such as Parkinson's Disease, Essential Tremor, Huntington's, Chorea, Dystonia (including but not limited to spasmodic torticollis, writers' cramp, spasmodic dysphonia, blepharospasm), Tics, and Spasticity.
In addition to pharmacotherapy, Dr. Danisi employs other treatment methods, including botulinum toxin injections, intrathecal baclofen pump management, and Deep Brain Stimulation. He is principal investigator for several clinical research trials in the fields of Parkinson's disease and Dystonia, and has published book chapters and peer-reviewed original articles on these topics.
Education
- M.D., Sapienza University of Rome
- Internship, Internal Medicine, Icahn School of Medicine at Mount Sinai
- Residency, Neurology, Icahn School of Medicine at Mount Sinai/Mount Sinai Hospital
Publications
- Schonwald A, Amodeo K, Levy V, et. al. "Botulinum toxin therapy in Parkinson disease-related lower limb dystonia. An 8 year retrospective review." Clinical parkinsonism & related disorders, 11(), (2024) 100260. doi: 10.1016/j.prdoa.2024.100260
- Cozzi FM, Zuckerman D, Sacknovitz A, et. al. "Outcomes, complications, and dosing of intrathecal baclofen in the treatment of multiple sclerosis: a systematic review." Neurosurgical focus, 56(6), (2024) E14. doi: 10.3171/2024.3.FOCUS2464
- Rascol O, Tönges L, deVries T, et. al. "Immediate-release/extended-release amantadine (OS320) to treat Parkinson's disease with levodopa-induced dyskinesia: Analysis of the randomized, controlled ALLAY-LID studies." Parkinsonism & related disorders, 96(), (2022) 65-73. doi: 10.1016/j.parkreldis.2022.01.022
- Parkinson Study Group STEADY-PD III Investigators. "Isradipine Versus Placebo in Early Parkinson Disease: A Randomized Trial." Annals of internal medicine, 172(9), (2020) 591-598. doi: 10.7326/M19-2534
- Shao MM, Liss A, Park YL, et. al. "Early Experience With New Generation Deep Brain Stimulation Leads in Parkinson's Disease and Essential Tremor Patients." Neuromodulation : journal of the International Neuromodulation Society, 23(4), (2020) 537-542. doi: 10.1111/ner.13034
- Danisi F, Guidi E. "Characterization and Treatment of Unilateral Facial Muscle Spasm in Linear Scleroderma: A Case Report." Tremor and other hyperkinetic movements (New York, N.Y.), 8(), (2018) 531. doi: 10.7916/D88S5XJP
- Ramirez-Zamora A, Kaszuba BC, Gee L, et. al. "Clinical Outcome and Characterization of Local Field Potentials in Holmes Tremor Treated with Pallidal Deep Brain Stimulation." Tremor and other hyperkinetic movements (New York, N.Y.), 6(), (2016) 388. doi: 10.7916/D8S182JJ
